H-TLPPAWQPFL-OH
Ref. 3D-PP46641
1mg | 232,00 € | ||
10mg | 273,00 € | ||
100mg | 497,00 € |
Informations sur le produit
- NH2-Thr-Leu-Pro-Pro-Ala-Trp-Gln-Pro-Phe-Leu-OH
Peptide H-TLPPAWQPFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TLPPAWQPFL-OH include the following: Dendritic cell vaccines targeting survivin in head and neck cancer WT Lee - Immunotherapy, 2013 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.2217/imt.13.120 Identification of a survivin-derived peptide that induces HLA-A* 0201-restricted antileukemia cytotoxic T lymphocytes S Siegel, J Steinmann, N Schmitz, R Stuhlmann - Leukemia, 2004 - nature.comhttps://www.nature.com/articles/2403510 Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma MJ Ciesielski, D Kozbor, CA Castanaro - Cancer Immunology , 2008 - Springerhttps://link.springer.com/article/10.1007/s00262-008-0510-9 ZnT8107-115/HLA-A2 dimers attenuate the severity of diabetes by inducing CD8+ T cell tolerance M Zhang, Z Zhou, J Wang, S Li - Immunology Letters, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247816302607 Generation of Survivin-specific CD8+ T Effector Cells by Dendritic Cells Pulsed with Protein or Selected Peptides M Schmitz, P Diestelkoetter, B Weigle - Cancer Research, 2000 - AACRhttps://aacrjournals.org/cancerres/article-abstract/60/17/4845/506525 The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer L Matera - Cancer treatment reviews, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0305737209001637 Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients AW Turksma, HJ Bontkes, JJ Ruizendaal - Journal of translational , 2013 - Springerhttps://link.springer.com/article/10.1186/1479-5876-11-152 Journal of Translational Medicine AW Turksma, HJ Bontkes, JJ Ruizendaal - Journal of , 2013 - researchgate.nethttps://www.researchgate.net/profile/Erik-Hooijberg/publication/240308496_Exploring_dendritic_cell_based_vaccines_targeting_survivin_for_the_treatment_of_head_and_neck_cancer_patients/links/02e7e5244560f773a8000000/Exploring-dendritic-cell-based-vaccines-targeting-survivin-for-the-treatment-of-head-and-neck-cancer-patients.pdf
Propriétés chimiques
Question d’ordre technique sur : 3D-PP46641 H-TLPPAWQPFL-OH
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages